Llwytho...
Synthetic Bax-Anti Bcl(2) combination module actuated by super artificial hTERT promoter selectively inhibits malignant phenotypes of bladder cancer
BACKGROUND: The synthetic biology technology which enhances the specificity and efficacy of treatment is a novel try in biomedical therapy during recent years. A high frequency of somatic mutations was shown in the human telomerase reverse transcriptase (hTERT) promoter in bladder cancer, indicating...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Exp Clin Cancer Res |
|---|---|
| Prif Awduron: | , , , , , , , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BioMed Central
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4705585/ https://ncbi.nlm.nih.gov/pubmed/26743236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-015-0279-6 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|